Company / Operating Income
PAVmed Inc. Operating Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$44.5M
FY2025
5-year range
-$91.1M / -$23.4M
FY2021-FY2025
Trend
+35.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$91M to -$44M over the past 2 years.
Based on SEC 10-K filings.
-$44M in FY2025.
Improved from -$91M to -$44M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 35.3% year-over-year.
- Peak operating income was recorded in FY2021.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$44.5M | +35.3% |
| FY2024 | -$68.8M | +24.5% |
| FY2023 | -$91.1M | -67.5% |
| FY2022 | -$54.4M | -132.9% |
| FY2021 | -$23.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026